This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Skin Cancer
+5

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Sponsored by University of Wisconsin, Madison

About this trial

Last updated 6 months ago

Study ID

2024-1143

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 5 months ago

What is this trial about?

The goal of this observational study is to study blood samples and compare them to other biospecimens and clinical outcomes in participants who have melanoma or non-melanoma skin cancers. The main question it aims to answer is: - Are blood based signatures able to predict progression-free survival (PFS)? Participants undergoing regular treatment for their skin cancer will provide blood samples.

What are the participation requirements?

Yes

Inclusion Criteria

- Age ≥18 years.

- Participants must meet at least one of the following criteria:

- Finding suspicious of melanoma or non-melanoma skin cancer based on clinical, radiographic, or laboratory findings. Non-melanoma skin cancers include: basal cell carcinoma, cutaneous squamous cell carcinoma, and Merkel cell carcinoma.

- A confirmed diagnosis of melanoma or non-melanoma skin cancer.

No

Exclusion Criteria

- Vulnerable populations, including pregnant women, those who lack consent capacity, the mentally ill, prisoners, cognitively impaired persons, children (age <18), and UW employees that report to the investigator(s) or to study team members.

- Not suitable for study participation due to other reasons at the discretion of the investigators.

Locations

Location

Status

Recruiting